Our site uses cookies to make navigation as functional as possible, including "third party" cookies and "profiling cookies" designed to tailor on-line contents to suit the preferences expressed while surfing the internet. Should you wish to receive more information, or deny your consent to some or all cookies, click here. If you proceed browsing this website, you will be consenting to the use of all cookies.

News

Monograph presented at Palazzo Pitti for the Italian Renaissance’s most famous female artist
The Menarini Group, a worldwide leader in the pharmaceutical industry, has chosen Google Cloud to help it work in a smarter and more flexible way, through the use of G Suite which will allow its 17,000 employees to work...
Menarini Ricerche  will present on the latest preclinical studies of its phosphatidylinositol 3-kinase (PI3K) class I inhibitor MEN1611, in development for solid tumors, at the AACR Annual Meeting 2018, which will take pla...
Pharmaceutical group Menarini, headed by the Aleotti family, has decided to entrust the  Chairmanship of the company  to an external manager coming from a large multinational,  Dr. Eric Cornut.  The new chairmanship will...
The Menarini Group announced today that on March 6th 2017 it has submitted a Marketing Authorization Application for delafloxacin at the European Medicines Agency (EMA) under the trade name Quofenix. The proposed indication ...
Menarini Ricerche was invited to present an update on MEN1112, a humanized monoclonal antibody targeting CD157, which is co-developed with Oxford BioTherapeutics for the treatment of acute myeloid leukemia (AML)
Oncology Alliance between Menarini & Oxford BioTherapeutics Progresses Second Candidate MEN1309 into the Clinic, an Antibody Drug Conjugate for the treatment of solid tumors and NHL
The Menarini Group has consolidated its presence in Latin America with new affiliates in Colombia and Peru. Both countries have emerging economies which offer the company opportunities for market expansion with its high-q...
All News »

Ambition

Through multi-faceted sponsorship activities, we are committed to continuing medical education and specialist training for medical professionals. Come and visit us at our stand.

National congresses

International congresse

   


Diagnostics

Advanced technology.

READ MORE »

Menarini in the world.

The Menarini Group has companies located almost all over the world.

READ MORE »

Our values

 

10 core values have influenced the progress of our group.

READ MORE »

Open positions

We are looking for talented people. Discover the opportunities!!

READ MORE »